Limits...
Multiplex pyrosequencing assay using AdvISER-MH-PYRO algorithm: a case for rapid and cost-effective genotyping analysis of prostate cancer risk-associated SNPs.

Ambroise J, Butoescu V, Robert A, Tombal B, Gala JL - BMC Med. Genet. (2015)

Bottom Line: Using multiplex genotyping approach for analyzing a set of 90 patients allowed reducing TAT by approximately 75 % (i.e., from 2025 to 470 min) while reducing reagent consumption and cost by approximately 70 % (i.e., from ~229 US$ /patient to ~64 US$ /patient).Using this combined multiplex approach also substantially reduced the production of waste material.In addition, the same approach could now equally be transposed to other clinical/research applications relying on the computation of MGRS based on multi-SNP genotyping.

View Article: PubMed Central - PubMed

Affiliation: Center for Applied Molecular Technologies (CTMA), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Clos chapelle-aux-champs B1.30.24, Brussels, 1200, Belgium.

ABSTRACT

Background: Single Nucleotide Polymorphisms (SNPs) identified in Genome Wide Association Studies (GWAS) have generally moderate association with related complex diseases. Accordingly, Multilocus Genetic Risk Scores (MGRSs) have been computed in previous studies in order to assess the cumulative association of multiple SNPs. When several SNPs have to be genotyped for each patient, using successive uniplex pyrosequencing reactions increases analytical reagent expenses and Turnaround Time (TAT). While a set of several pyrosequencing primers could theoretically be used to analyze multiplex amplicons, this would generate overlapping primer-specific pyro-signals that are visually uninterpretable.

Methods: In the current study, two multiplex assays were developed consisting of a quadruplex (n=4) and a quintuplex (n=5) polymerase chain reaction (PCR) each followed by multiplex pyrosequencing analysis. The aim was to reliably but rapidly genotype a set of prostate cancer-related SNPs (n=9). The nucleotide dispensation order was selected using SENATOR software. Multiplex pyro-signals were analyzed using the new AdvISER-MH-PYRO software based on a sparse representation of the signal. Using uniplex assays as gold standard, the concordance between multiplex and uniplex assays was assessed on DNA extracted from patient blood samples (n = 10).

Results: All genotypes (n=90) generated with the quadruplex and the quintuplex pyroquencing assays were perfectly (100 %) concordant with uniplex pyrosequencing. Using multiplex genotyping approach for analyzing a set of 90 patients allowed reducing TAT by approximately 75 % (i.e., from 2025 to 470 min) while reducing reagent consumption and cost by approximately 70 % (i.e., from ~229 US$ /patient to ~64 US$ /patient).

Conclusions: This combination of quadruplex and quintuplex pyrosequencing and PCR assays enabled to reduce the amount of DNA required for multi-SNP analysis, and to lower the global TAT and costs of SNP genotyping while providing results as reliable as uniplex analysis. Using this combined multiplex approach also substantially reduced the production of waste material. These genotyping assays appear therefore to be biologically, economically and ecologically highly relevant, being worth to be integrated in genetic-based predictive strategies for better selecting patients at risk for prostate cancer. In addition, the same approach could now equally be transposed to other clinical/research applications relying on the computation of MGRS based on multi-SNP genotyping.

Show MeSH

Related in: MedlinePlus

Example of a quadruplex (left) and quintuplex (right) pyro-signal identification with AdvISER-MH-PYRO.The multiplex pyro-signal generated by the pyrosequencing machine is displayed before (top) and after (bottom) the analysis. In both cases, it is represented by vertical black lines. After analysis, the contribution of each atom (i.e., each uniplex pyro-signal within the dictionary) is represented by colored boxes stacked on top of the other
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4630960&req=5

Fig3: Example of a quadruplex (left) and quintuplex (right) pyro-signal identification with AdvISER-MH-PYRO.The multiplex pyro-signal generated by the pyrosequencing machine is displayed before (top) and after (bottom) the analysis. In both cases, it is represented by vertical black lines. After analysis, the contribution of each atom (i.e., each uniplex pyro-signal within the dictionary) is represented by colored boxes stacked on top of the other

Mentions: Figure 3 illustrates the results obtained with AdvISER-MH-PYRO when applied on quadruplex (left) and quintuplex (right) pyro-signals generated for the first patient. Both signals are correctly converted into four and five genotypes, respectively.Fig. 3


Multiplex pyrosequencing assay using AdvISER-MH-PYRO algorithm: a case for rapid and cost-effective genotyping analysis of prostate cancer risk-associated SNPs.

Ambroise J, Butoescu V, Robert A, Tombal B, Gala JL - BMC Med. Genet. (2015)

Example of a quadruplex (left) and quintuplex (right) pyro-signal identification with AdvISER-MH-PYRO.The multiplex pyro-signal generated by the pyrosequencing machine is displayed before (top) and after (bottom) the analysis. In both cases, it is represented by vertical black lines. After analysis, the contribution of each atom (i.e., each uniplex pyro-signal within the dictionary) is represented by colored boxes stacked on top of the other
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4630960&req=5

Fig3: Example of a quadruplex (left) and quintuplex (right) pyro-signal identification with AdvISER-MH-PYRO.The multiplex pyro-signal generated by the pyrosequencing machine is displayed before (top) and after (bottom) the analysis. In both cases, it is represented by vertical black lines. After analysis, the contribution of each atom (i.e., each uniplex pyro-signal within the dictionary) is represented by colored boxes stacked on top of the other
Mentions: Figure 3 illustrates the results obtained with AdvISER-MH-PYRO when applied on quadruplex (left) and quintuplex (right) pyro-signals generated for the first patient. Both signals are correctly converted into four and five genotypes, respectively.Fig. 3

Bottom Line: Using multiplex genotyping approach for analyzing a set of 90 patients allowed reducing TAT by approximately 75 % (i.e., from 2025 to 470 min) while reducing reagent consumption and cost by approximately 70 % (i.e., from ~229 US$ /patient to ~64 US$ /patient).Using this combined multiplex approach also substantially reduced the production of waste material.In addition, the same approach could now equally be transposed to other clinical/research applications relying on the computation of MGRS based on multi-SNP genotyping.

View Article: PubMed Central - PubMed

Affiliation: Center for Applied Molecular Technologies (CTMA), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Clos chapelle-aux-champs B1.30.24, Brussels, 1200, Belgium.

ABSTRACT

Background: Single Nucleotide Polymorphisms (SNPs) identified in Genome Wide Association Studies (GWAS) have generally moderate association with related complex diseases. Accordingly, Multilocus Genetic Risk Scores (MGRSs) have been computed in previous studies in order to assess the cumulative association of multiple SNPs. When several SNPs have to be genotyped for each patient, using successive uniplex pyrosequencing reactions increases analytical reagent expenses and Turnaround Time (TAT). While a set of several pyrosequencing primers could theoretically be used to analyze multiplex amplicons, this would generate overlapping primer-specific pyro-signals that are visually uninterpretable.

Methods: In the current study, two multiplex assays were developed consisting of a quadruplex (n=4) and a quintuplex (n=5) polymerase chain reaction (PCR) each followed by multiplex pyrosequencing analysis. The aim was to reliably but rapidly genotype a set of prostate cancer-related SNPs (n=9). The nucleotide dispensation order was selected using SENATOR software. Multiplex pyro-signals were analyzed using the new AdvISER-MH-PYRO software based on a sparse representation of the signal. Using uniplex assays as gold standard, the concordance between multiplex and uniplex assays was assessed on DNA extracted from patient blood samples (n = 10).

Results: All genotypes (n=90) generated with the quadruplex and the quintuplex pyroquencing assays were perfectly (100 %) concordant with uniplex pyrosequencing. Using multiplex genotyping approach for analyzing a set of 90 patients allowed reducing TAT by approximately 75 % (i.e., from 2025 to 470 min) while reducing reagent consumption and cost by approximately 70 % (i.e., from ~229 US$ /patient to ~64 US$ /patient).

Conclusions: This combination of quadruplex and quintuplex pyrosequencing and PCR assays enabled to reduce the amount of DNA required for multi-SNP analysis, and to lower the global TAT and costs of SNP genotyping while providing results as reliable as uniplex analysis. Using this combined multiplex approach also substantially reduced the production of waste material. These genotyping assays appear therefore to be biologically, economically and ecologically highly relevant, being worth to be integrated in genetic-based predictive strategies for better selecting patients at risk for prostate cancer. In addition, the same approach could now equally be transposed to other clinical/research applications relying on the computation of MGRS based on multi-SNP genotyping.

Show MeSH
Related in: MedlinePlus